BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21625507)

  • 1. Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells.
    Luciani MG; Seok J; Sayeed A; Champion S; Goodson WH; Jeffrey SS; Xiao W; Mindrinos M; Davis RW; Dairkee SH
    PLoS One; 2011; 6(5):e20016. PubMed ID: 21625507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
    Triulzi T; Casalini P; Sandri M; Ratti M; Carcangiu ML; Colombo MP; Balsari A; Ménard S; Orlandi R; Tagliabue E
    PLoS One; 2013; 8(2):e56761. PubMed ID: 23441215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
    Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A
    J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.
    Björner S; Fitzpatrick PA; Li Y; Allred C; Howell A; Ringberg A; Olsson H; Miller CJ; Axelson H; Landberg G
    PLoS One; 2014; 9(8):e105099. PubMed ID: 25122196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
    Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
    Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.
    Rajski M; Zanetti-Dällenbach R; Vogel B; Herrmann R; Rochlitz C; Buess M
    BMC Med; 2010 Jan; 8():1. PubMed ID: 20051100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
    Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
    Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome.
    Myhre S; Mohammed H; Tramm T; Alsner J; Finak G; Park M; Overgaard J; Børresen-Dale AL; Frigessi A; Sørlie T
    PLoS One; 2010 Nov; 5(11):e14002. PubMed ID: 21124964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
    Potter SM; Dwyer RM; Hartmann MC; Khan S; Boyle MP; Curran CE; Kerin MJ
    Breast Cancer Res Treat; 2012 Jan; 131(2):401-11. PubMed ID: 21344235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.
    Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M
    Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
    Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
    Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
    Migneco G; Whitaker-Menezes D; Chiavarina B; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Flomenberg N; Tsirigos A; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2010 Jun; 9(12):2412-22. PubMed ID: 20562527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
    Al-Rakan MA; Hendrayani SF; Aboussekhra A
    BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.